Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
Authors
Keywords
Rhesus Macaque, Cynomolgus Macaque, Formal Safety Assessment, EBOV Infection, Peak Viral Load
Journal
CLINICAL PHARMACOKINETICS
Volume 55, Issue 8, Pages 907-923
Publisher
Springer Nature
Online
2016-01-22
DOI
10.1007/s40262-015-0364-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
- (2016) Daouda Sissoko et al. PLOS MEDICINE
- Ebola virus dynamics in mice treated with favipiravir
- (2015) Vincent Madelain et al. ANTIVIRAL RESEARCH
- The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
- (2015) Johan van Griensven et al. CLINICAL INFECTIOUS DISEASES
- The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
- (2015) Colleen S. Kraft et al. CLINICAL INFECTIOUS DISEASES
- Favipiravir for children with Ebola
- (2015) Naïm Bouazza et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- Dose regimen of favipiravir for Ebola virus disease
- (2015) France Mentré et al. LANCET INFECTIOUS DISEASES
- Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases
- (2015) Claire M Tully et al. LANCET INFECTIOUS DISEASES
- Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates
- (2015) Emily P. Thi et al. NATURE
- Persistence of Ebola Virus in Ocular Fluid during Convalescence
- (2015) Jay B. Varkey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Implications of Antiviral Resistance in Influenza
- (2015) Timothy Li et al. Viruses-Basel
- A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus Infection
- (2015) Travis K. Warren et al. mBio
- Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo
- (2015) Nanikaly Moyen et al. PLoS Neglected Tropical Diseases
- The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients
- (2014) Maya Hites et al. ADVANCED DRUG DELIVERY REVIEWS
- Caring for Critically Ill Patients with Ebola Virus Disease. Perspectives from West Africa
- (2014) Robert A. Fowler et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies
- (2014) Alison E. Heald et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
- (2014) Sophie J. Smither et al. ANTIVIRAL RESEARCH
- Interferons: Success in anti-viral immunotherapy
- (2014) Fan-ching Lin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Characterization of host immune responses in Ebola virus infections
- (2014) Gary Wong et al. Expert Review of Clinical Immunology
- Treatment of Ebola virus disease
- (2014) Yazdan Yazdanpanah et al. INTENSIVE CARE MEDICINE
- The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
- (2014) Gerrit Gehring et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical features and pathobiology of Ebolavirus infection
- (2014) Aftab A. Ansari JOURNAL OF AUTOIMMUNITY
- Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent
- (2014) Mark C. Rogge et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Viral kinetic modeling: state of the art
- (2014) Laetitia Canini et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
- (2014) Travis K. Warren et al. NATURE
- Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
- (2014) John S. Schieffelin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structures of protective antibodies reveal sites of vulnerability on Ebola virus
- (2014) Charles D. Murin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ebola virus disease
- (2014) N. J. Beeching et al. BMJ-British Medical Journal
- Favipiravir elicits antiviral mutagenesis during virus replication in vivo
- (2014) Armando Arias et al. eLife
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013
- (2013) Alexander A. Bukreyev et al. ARCHIVES OF VIROLOGY
- Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection
- (2013) Charles J. Shoemaker et al. PLoS One
- Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
- (2013) J. Pettitt et al. Science Translational Medicine
- Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
- (2013) Xiangguo Qiu et al. Scientific Reports
- Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever
- (2012) Lauren M. Smith et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacology and therapeutic potential of interferons
- (2012) Peter M. George et al. PHARMACOLOGY & THERAPEUTICS
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
- (2012) G. G. Olinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
- (2012) Patrick Iversen et al. Viruses-Basel
- Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly
- (2012) Gregory Neveu et al. PLoS Pathogens
- Nonhuman primates as models for the discovery and development of ebolavirus therapeutics
- (2011) Amy C Shurtleff et al. Expert Opinion on Drug Discovery
- Identification of a Small-Molecule Entry Inhibitor for Filoviruses
- (2011) A. Basu et al. JOURNAL OF VIROLOGY
- Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
- (2011) Marceline Côté et al. NATURE
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
- (2011) L. Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiviral Activity of a Small-Molecule Inhibitor of Filovirus Infection
- (2010) T. K. Warren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
- (2010) Jens H. Kuhn et al. ARCHIVES OF VIROLOGY
- Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
- (2010) Thomas W Geisbert et al. LANCET
- Ebola haemorrhagic fever
- (2010) Heinz Feldmann et al. LANCET
- Advanced antisense therapies for postexposure protection against lethal filovirus infections
- (2010) Travis K Warren et al. NATURE MEDICINE
- A broad-spectrum antiviral targeting entry of enveloped viruses
- (2010) M. C. Wolf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a broad-spectrum antiviral with activity against Ebola virus
- (2009) M. Javad Aman et al. ANTIVIRAL RESEARCH
- Evasion of Interferon Responses by Ebola and Marburg Viruses
- (2009) Christopher F. Basler et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The promises and pitfalls of RNA-interference-based therapeutics
- (2009) Daniela Castanotto et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now